MNA � According to a cooperation agreement inked between Iran and Qatar, Iranian drugs will be exported to Qatar.


Under the agreement, hard-to-cure Qatari patients and also patients suffering from cancer will use Iranian-made drugs and medicines.

For this purpose, a joint cooperation agreement was signed yesterday between Dr. Haleh Hamedifar,�Chief Executive of CinnaGen Pharmaceutical Group and Qatari pharmaceutical officials in order to supply Iranian medicines to Qatari patients suffering from special diseases.

Given the above issue, Iran�s CinnaGen Pharmaceutical Group undertook to supply more than 40 �hi-tech� drugs for Qatari patients from its production sites based on Iran and Turkey.

As the first and sole Iranian company, CinnaGen Pharmaceutical Group is licensed by EU�s GMP (Good Manufacturing Practice) and is the largest and most reliable knowledge-based company in country�s pharmaceutical industry. The Group accounts for 30% of Iran�s total pharmaceutical export share.

Providing medicines and drugs for special and hard-to-cure patients is a major concern for all governments in the world at the current situation. The use of biochemical products can raise a hope for the treatment of a great number of patients who are in in need of medication across the world.